Stubbs Alderton & Markiles’ client Consortia Health Holdings, Inc., a Personalized Pelvic Wellness health care company that provides clinically-relevant individualized diagnosis, therapy and education to help physicians treat their patients with incontinence, pelvic pain, sexual dysfunction and other pelvic disorders, today announced that it has closed a $2 million preferred round of financing. The round was led by Ponil Ventures, a current investor, and included Golden Seeds and Belle Michigan as new investors. The new financing will fund the growth needed to assist Consortia Health as they continue building the leading Pelvic Wellness Company.
To read the full article about Consortia Health click here.
About Consortia Health
Consortia Health Holdings, Inc., is a personalized medicine company providing an integrated delivery model in partnership with physicians to provide diagnosis, treatment, and educational support to address pelvic floor disorders including urinary incontinence, pelvic pain and sexual health. Consortia Health is a leading provider of these services in the US and has been a trusted partner transforming patient lives. Consortia Health is focused on three strategic imperatives: becoming the worldwide leader in clinical continence services, expanding into the assisted living market and diversifying by offering a product portfolio while increasing revenue from international expansion. For more on how Consortia Health is making a difference, please visit the Company’s website at www.ConsortiaHealth.com.
For more information about our Venture Capital and Emerging Growth Practice , contact Scott Alderton at firstname.lastname@example.org